期刊文献+

Presepsin在脓毒症早期患者中的临床应用 被引量:12

原文传递
导出
摘要 脓毒症是感染所致的全身炎症反应综合征,其临床表现多样,病情进展迅速,不仅使患者生存质量下降,治疗费用高昂,而且病死率高,已成重症监护病房患者的死亡原因之一。近年来,许多生物学标记物如降钙素原(PCT)、白细胞介素、C-反应蛋白、
出处 《中华急诊医学杂志》 CAS CSCD 北大核心 2015年第1期86-88,共3页 Chinese Journal of Emergency Medicine
  • 相关文献

参考文献8

  • 1Chart T, Gu F. Early diagnosis of sepisis using serum biomarkers [J]. Exper Rev Mol Diagn, 2011, 11 (5) : 487-496.
  • 2杨毅,邱海波.正确认识生物标记物在全身性感染诊治中的价值[J].中华急诊医学杂志,2011,20(12):1240-1242. 被引量:6
  • 3叶子,詹红.感染性疾病的早期诊断及预后评估相关指标的研究进展[J].中华急诊医学杂志,2012,21(6):667-669. 被引量:10
  • 4Tang BM, Eslick GD, Craig JC, et al. Accuracy of procalcitoninfor sepsis diagnosis in critically ill patients: systematic review and meta-analysis [J], Lancet Infect Dis, 2007, 7 (3): 210-217.
  • 5Shirakawa K, Naitou K, Hirose J, et al. The new sepsis marker, Scdl4-ST, induction mechanism in the rabbit sepsis models [ J], Critical Care, 2010, 14 Suppl 2: S19.
  • 6Spanuth E, Wilhelm J, Loppnow H, et al. Diagnostic and prognostic value of presepsin in emergency patients with early sepsis using the new assay PATHFAST presepsin [ C ] //21st International congress of clinical chemistry and laboratory medicine, IFCC-World Labeuro Med Lab, Berlin, 2011 : 15-19.
  • 7Caironi P, Masson S, Spanuth E, et al. Comparel values of presepsin and procalcitonin as early markers of outcome in severe sepsis and septic shock: a preliminary report from the Albumin Italian Outcome Spsis study [ J]. Crit Care, 2013, 17 (Suppl 2): $35.
  • 8Sato R, Suzuki Y, Sato M, et al. Serum levels of presepsin reflects the APACHE II and SOFA scores inpatients with sepsis [J]. Crit Care, 2013, 17 (Suppl2): $37.

二级参考文献26

  • 1赵静,秦俭,杨淑芳.C反应蛋白和临床肺部感染评分在老年社区获得性肺炎预后评估中的作用[J].首都医科大学学报,2007,28(4):450-453. 被引量:32
  • 2Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000 [J]. N Engl J Med, 2003, 348 (16): 1546-1554.
  • 3Marshall JC , Reinhart K. Biomarkers of sepsis [ J ]. Crit Care Med, 2009, 37 (7) : 2290-2298.
  • 4Chan T, Gu F. Early diagnosis of sepsis using serum biomarkers [J]. Expert Rev Mol Diagn, 2011, 11 (5) : 487-496.
  • 5Uzzan B, Cohen R, Nicolas P, et al. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis [ J]. Crit Care Med, 2006, 34 (7) : 1-8.
  • 6Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations [J]. Crit Care Med, 2008, 36 (3) : 941-952.
  • 7Limper M, de Kruif MD, Duits A J, et al. The diagnostic role of procalcitonin and other biomarkers in discriminating infectious from non-infectious fever [J]. J Infect, 2010, 60 (6) : 409-416.
  • 8Cuquemelle E, Soulis F, Villers D, et al. Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? a muhicentre study [ J ]. Intensive Care Med, 2011, 37 (5) : 796-800.
  • 9Petrikkos GL, Christofilopoulou SA, Tentolouris NK. Value of measuring serum procalcitonin, C-reactive protein, and mannan antigens to distinguish fungal from bacterial infections [ J ]. Eur J Clin Microbiol Infect Dis, 2005, 24 (4) : 272-275.
  • 10Bouchon A, Faechetti F, Weigand MA, et al. TREM-1 amplifies inflammation and is a crucial mediator of septic shock [ J ]. Nature, 2001, 410 (26) : 1103-1107.

共引文献12

同被引文献63

引证文献12

二级引证文献137

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部